Page last updated: 2024-10-24

carteolol and Prinzmetal Angina

carteolol has been researched along with Prinzmetal Angina in 1 studies

Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.

Research Excerpts

ExcerptRelevanceReference
" Ophthalmic carteolol eye drops are nonselective beta-blockers and effective against glaucoma and ocular hypertension."4.31Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops. ( Akashi, R; Eto, R; Ikeda, S; Kawano, H; Maemura, K; Suzuki, A, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Eto, R2
Kawano, H2
Suzuki, A2
Akashi, R2
Ikeda, S2
Maemura, K2

Other Studies

1 other study available for carteolol and Prinzmetal Angina

ArticleYear
Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops.
    Internal medicine (Tokyo, Japan), 2023, Sep-01, Volume: 62, Issue:17

    Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Carteolol; Coronary Vasospasm; Glaucoma; Huma

2023
Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops.
    Internal medicine (Tokyo, Japan), 2023, Sep-01, Volume: 62, Issue:17

    Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Carteolol; Coronary Vasospasm; Glaucoma; Huma

2023
Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops.
    Internal medicine (Tokyo, Japan), 2023, Sep-01, Volume: 62, Issue:17

    Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Carteolol; Coronary Vasospasm; Glaucoma; Huma

2023
Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops.
    Internal medicine (Tokyo, Japan), 2023, Sep-01, Volume: 62, Issue:17

    Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Carteolol; Coronary Vasospasm; Glaucoma; Huma

2023